Stocks · Korea
246250
KOSDAQ
SLSBio(Specialty Lab Solution Bio)
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-07 basis
Returns and 52-week range
1W+0.00%
1M+0.00%
3M+0.00%
6M+0.00%
1Y+0.00%
YTD+0.00%
Financial results (separate)
| Period | Revenue | Operating income | Net income | OP margin |
|---|---|---|---|---|
| 2022 | 108억 | 24억 | 28억 | 22.5% |
| 2023 | 90억 | 10억 | 14억 | 11.4% |
| 2024 | 84억 | 3억 | 3억 | 3.4% |
| 2025 | 40억 | -41억 | -49억 | -103.0% |
| Quarterly | ||||
| 2024 4Q | 18억 | -2억 | -3억 | -10.7% |
| 2025 1Q | 18억 | -2억 | -2억 | -12.5% |
| 2025 2Q | 16억 | -7억 | -12억 | -42.4% |
| 2025 3Q | 3억 | -18억 | -19억 | -608.8% |
| 2025 4Q | 3억 | -14억 | -16억 | -413.6% |
| 2026 1Q | 10억 | -10억 | -9억 | -99.2% |
Company
Address: 경기도 수원시 영통구 창룡대로 260, 광교센트럴비즈타워7층 (이의동)
Peers in the same sector
Recent filings
- 2026-08-14반기보고서 (2026.06)
- 2026-06-29[기재정정]사업보고서 (2025.12)
- 2026-06-02[기재정정]분기보고서 (2026.03)
- 2026-05-15분기보고서 (2026.03)
Source: DART (Financial Supervisory Service electronic disclosure)
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.